Description

Description

Tagipmet is a fixed-dose combination medicine manufactured by Highnoon Laboratories, formulated with two active ingredients — Sitagliptin (50mg) and Metformin (500mg) — in each tablet. This pack contains 20 tablets designed for adults managing type 2 diabetes mellitus who require a dual-action approach to blood sugar control. By combining two medicines with different mechanisms of action into a single tablet, Tagipmet offers a more convenient treatment option for patients whose blood sugar is not adequately controlled on Metformin alone, or for those already stabilized on both medicines separately at matching doses. Sitagliptin, a DPP-4 inhibitor, works by increasing levels of natural hormones that help the pancreas release more insulin when blood sugar is high while also reducing glucose production by the liver, offering a relatively gentle safety profile with a lower likelihood of causing significant drops in blood sugar on its own. Metformin complements this by further reducing liver glucose output and improving the body’s sensitivity to insulin. Together, these two mechanisms support more comprehensive glycemic control. Tagipmet is intended to be used alongside lifestyle measures such as a controlled diet, regular physical activity, and consistent blood sugar monitoring, and should only be taken under the ongoing supervision of a qualified healthcare provider.

Ingredients

Each tablet of Tagipmet contains two active pharmaceutical ingredients: Sitagliptin 50mg, a DPP-4 inhibitor that supports insulin release and reduces liver glucose production, and Metformin Hydrochloride 500mg, a biguanide-class medicine that helps regulate liver glucose production and improves insulin sensitivity in body tissues. The tablet formulation also contains standard pharmaceutical excipients, including binding and coating agents, which support tablet integrity, stability, and consistent release of the active ingredients.

Dosage Form

Tagipmet is available as an oral film-coated tablet, with each tablet containing a combined strength of 50mg Sitagliptin and 500mg Metformin. The pack contains 20 tablets, offering a supply typically aligned with ongoing prescription cycles as directed by a treating physician.

Uses

Tagipmet is used to help improve blood sugar control in adults with type 2 diabetes mellitus, particularly in cases where treatment with Metformin alone has not provided adequate glycemic control, or where a doctor determines that combination therapy with a DPP-4 inhibitor would be beneficial. It is generally prescribed as part of a broader diabetes management plan and may be used alongside other antidiabetic therapies depending on individual patient requirements. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

How to Use

Tagipmet tablets are typically taken twice daily with meals, as directed by a physician, to help reduce the likelihood of gastrointestinal discomfort associated with Metformin. Tablets should be swallowed whole with a glass of water and should not be crushed, split, or chewed unless specifically advised. The exact dosage, frequency, and duration of treatment should be determined by a healthcare provider based on individual blood sugar levels, kidney function, and response to therapy. If a dose is missed, it should be taken as soon as remembered unless it is close to the time of the next dose, in which case the missed dose should be skipped rather than doubled.

Side Effects

Tagipmet may cause side effects in some individuals, and not all users will experience them. Commonly reported effects include gastrointestinal disturbances such as nausea, diarrhea, or stomach discomfort, particularly during the initial period of use, along with headache and upper respiratory symptoms associated with the Sitagliptin component. Some patients may also experience a metallic taste in the mouth. In rare instances, more serious effects such as lactic acidosis (linked to Metformin), pancreatitis, or severe allergic reactions (linked to Sitagliptin) have been reported, and immediate medical attention should be sought if symptoms such as severe abdominal pain, unusual tiredness, difficulty breathing, or persistent vomiting occur.

Pregnancy & Breastfeeding

Tagipmet is generally not recommended during pregnancy. While Metformin has been used in certain pregnancy-related conditions under strict medical supervision, the safety of Sitagliptin during pregnancy has not been well established, and insulin is typically preferred for blood sugar management during this period. Women who are pregnant, planning to become pregnant, or suspect pregnancy should consult their doctor immediately. For breastfeeding mothers, the safety of this combination has not been well established, and alternative diabetes management options are usually considered during this period. Any decisions regarding use during pregnancy or breastfeeding should be made exclusively in consultation with a healthcare provider.

Storage Instructions

Tagipmet tablets should be stored at room temperature in a cool, dry place, away from direct sunlight, heat, and moisture. Tablets should remain in their original packaging until use to protect them from environmental exposure. Keep out of reach of children and pets, and avoid using the medication beyond its printed expiry date. Expired or unused tablets should be disposed of responsibly, following local pharmaceutical waste disposal guidelines rather than being discarded in regular household trash.

FAQs

Can Tagipmet replace two separate medicines I’m currently taking?
In many cases, yes, if your doctor has prescribed both Sitagliptin and Metformin separately at matching doses, but this switch should only be made under medical guidance.

Does Tagipmet cause low blood sugar?
The risk of hypoglycemia with this combination is relatively low compared to some other diabetes medicines, though it can still occur, particularly if combined with additional antidiabetic therapies.

Does Tagipmet cause stomach upset?
Metformin, one of its components, may cause mild gastrointestinal discomfort initially, which often improves when taken with food and over time.

Is Tagipmet suitable for patients with kidney problems?
Both active ingredients require adequate kidney function for safe use, so patients with impaired kidney function should be evaluated carefully by their doctor before starting this medicine.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.